Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
The Impact of Psoriatic Disease
Main navigation
Toggle menu
Our Company
Toggle menu
About Us
Toggle menu
Management
Toggle menu
Sustainability
Toggle menu
Health of the planet
Toggle menu
Partnering
Toggle menu
Suppliers
Toggle menu
Requisition to Pay Process
Toggle menu
Our Team
Toggle menu
Become our supplier
Toggle menu
Funding
Toggle menu
USA
Toggle menu
Other countries
Toggle menu
Disclosure Of Payments
Toggle menu
Disclosure of payments to Healthcare Professionals
Toggle menu
Denmark
Toggle menu
Belgium
Toggle menu
Finland
Toggle menu
Sweden
Toggle menu
Hungary
Toggle menu
Italy
Toggle menu
Netherlands
Toggle menu
Ukraine
Toggle menu
Ireland
Toggle menu
Norway
Toggle menu
Romania
Toggle menu
Digital Business Transformation
Toggle menu
Ethical Business Practices
Toggle menu
Disease Areas
Toggle menu
Disease areas
Toggle menu
Our Science
Toggle menu
Overview
Toggle menu
Drug discovery
Toggle menu
Capabilities
Toggle menu
R&D locations
Toggle menu
Clinical studies
Toggle menu
Innovation is
Toggle menu
Pipeline
Toggle menu
Clinical Studies
Toggle menu
Overview
Toggle menu
Current studies
Toggle menu
Clinical studies index
Toggle menu
Alprazolam
Toggle menu
Alprostadil (Prostavasin®)
Toggle menu
Baclofen (Kemstro®)
Toggle menu
Bepranemab (UCB0107)
Toggle menu
Bimekizumab (Bimzelx®)
Toggle menu
Brivaracetam (Briviact®)
Toggle menu
CDP323
Toggle menu
CDP791
Toggle menu
Carbidopa,Levodopa (Parcopa®)
Toggle menu
Certolizumab Pegol (Cimzia®)
Toggle menu
Dapirolizumab pegol
Toggle menu
Doxecitine and doxribtimine (MT1621)
Toggle menu
Epratuzumab
Toggle menu
Fenfluramine (Fintepla)
Toggle menu
Ferrous(II) glycine sulphate complex (Ferro Sanol®)
Toggle menu
Ginisortamab (UCB6114)
Toggle menu
Hydrocodone Bitartrate controlled release (HC-CR)
Toggle menu
Hydrocodone bitartrate extended release (HC-ER)
Toggle menu
Intraject® Sumatriptan
Toggle menu
Lacosamide (Vimpat®)
Toggle menu
Levetiracetam (Keppra®)
Toggle menu
Levocetirizine (Xyzal®)
Toggle menu
MT1621
Toggle menu
Olokizumab
Toggle menu
Padsevonil (UCB0942)
Toggle menu
Piracetam (Nootropil®)
Toggle menu
Radiprodil
Toggle menu
Risperidone-SABER®
Toggle menu
Romosozumab (EVENITY®)
Toggle menu
Rotigotine (Neupro®)
Toggle menu
Rozanolixizumab (UCB7665)
Toggle menu
Seletalisib (UCB5857)
Toggle menu
Seletracetam
Toggle menu
Staccato Alprazolam
Toggle menu
UCB0022
Toggle menu
UCB0059
Toggle menu
UCB1381
Toggle menu
UCB6114
Toggle menu
UCB7853
Toggle menu
UCB9741
Toggle menu
Zampilimab (UCB7858)
Toggle menu
Zilucoplan (RA101495)
Toggle menu
General information
Toggle menu
Data Transparency Policy
Toggle menu
Our Products
Toggle menu
Products
Toggle menu
Bimzelx®
Toggle menu
Briviact®
Toggle menu
Cimzia® - Ankylosing spondylitis (AS)
Toggle menu
Cimzia® - Axial spondyloarthritis (axSpA)
Toggle menu
Cimzia® - Crohn's disease
Toggle menu
Cimzia® - Plaque psoriasis (PsO)
Toggle menu
Cimzia® - Psoriatic arthritis (PsA)
Toggle menu
Cimzia® - Rheumatoid arthritis (RA)
Toggle menu
Evenity®
Toggle menu
Fintepla®
Toggle menu
Keppra®
Toggle menu
Nayzilam
Toggle menu
Neupro® - Parkinson's disease
Toggle menu
Neupro® - Restless Legs Syndrome
Toggle menu
Vimpat®
Toggle menu
Newsroom
Toggle menu
Overview
Toggle menu
Press releases
Toggle menu
Our stories
Toggle menu
Resources
Toggle menu
Contact
Toggle menu
Healthcare Professionals
Toggle menu
HCP Overview
Toggle menu
Dermatology
Toggle menu
Women of childbearing age
Toggle menu
Immune to the impossible
Toggle menu
Patients
Toggle menu
Overview
Toggle menu
Life stories
Toggle menu
Women of Childbearing Age
Toggle menu
Investors
Toggle menu
Overview
Toggle menu
UCB equity story
Toggle menu
UCB financials
Toggle menu
UCB Governance
Toggle menu
UCB shareholders
Toggle menu
Shareholders meeting 2021
Toggle menu
ESG overview
Toggle menu
Download center
Toggle menu
IR team
Toggle menu
Careers
Toggle menu
Applying to UCB
Listen
You are here
Advantage Hers
Advantage Hers English
The Impact of Psoriatic Disease
The Impact of Psoriatic Disease on a Woman’s Career, Family Planning, Social Life and Mental Health
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – Inglês
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss